Abstract
When calculating the elimination rate of radioactivity after the administration of radioiodinated heptadecanoic acid (123I-HDA), background correction is necessary due to the high level of background activity. In the present study, the subtraction method of Freundlieb et al. was investigated on validity. This was done by comparing the half-time values of the elimination rate after intravenous (i.v.) and intracoronary (i.c.) injection. In the latter case, no background correction was necessary. Six patients underoging cardiac catheterization were studied. Scintigraphy was performed after the injection of 123I-HDA into the left coronary artery and after i.v. injection. Half-time values were calculated from regions of interest drawn over myocardium perfused by the left-anterior descending branch (LAD) and the left circumflex artery (LCX). In the LAD region, the mean half-time value in the i.c. study was 22 min, while in the corrected i.v. study, the mean value was 27 min. In the LCX region, the half-time values were 24 and 33 min, respectively. The background-subtraction procedure proposed by Freundlieb et al. for i.v.-injected 123I-HDA ss incomplete, as it resulted in half-time values that were higher than those of the i.c. study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Heart Association (AHA) Committee Report (1975) A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, council on cardiovascular surgery. Circulation 51 (suppl 4):5–40
Aurich D, Reske SN, Biersack HJ, Schmidt H, Simon HJ, Knopp R, Winkler C (1982) Biplanar sequential scintigraphy of the myocardium by means of 123I-heptadecanoic acid. In: Raynaud C (ed) Proceedings of the 3rd World Congress on Nuclear Medicine and Biology, Paris, 1982, vol 2. Pergamon Press, Oxford New York, pp 1389–1391
Carlsten A, Hallgren B, Jagenburg R, Svanborg A, Werko L (1961) Myocardial metabolism of glucose, lactic acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads. Scand J Clin Lab Invest 13:418–425
Comet M, Wolf JE, Pilichowski P, Mathieu JP, Dubois F, Riche F, Busquet G, Vidal M, Godart J, Pernin C, Gaudy M (1982) Influence du propranolol sur l'activite myocardique apres injection i.v. d'acide 16 I(123) hexadecene 9 oique. In: Bertrand A, Cherrier F, Amor M, Neimann JL (eds) Non-invasive methods in ischemic heart disease. Specia, Nancy, pp 295–299
Dudczak R, Schmoliner R, Pichler M, Frischauf H, Moesslacher H (1981) Myocardial imaging with I-123 heptadecanoic acid assessment of regional myocardial fatty acid metabolism. In: Schmidt HAE, Roesler H (eds) Proceedings of the 19th International Annual Meeting of the European Society of Nuclear Medicine, Bern 1981, vol 1., p 173
Dudczak R, Schmoliner R, Derfler DK, Angelberger P, Kletter K, Losert U, Frischauf H (1982) Effect of ischemia and pharmacological intervention on the myocardial elimination of I-123 heptadecanoic acid. J Nucl Med 23:P34
Evans JR (1964) Importance of fatty acid in myocardial metabolism. Circ Res 14 (suppl 2):96–107
Feinendegen LE, Vyska K, Freundlieb C, Hoeck A, Machulla HJ, Kloster G, Stoecklin G (1981) Non-invasive analysis of metabolic reactions in body tissues, the case of myocardial fatty acids. Eur J Nucl Med 6:191–200
Freundlieb C, Hoeck A, Vyska K, Feinendegen LE, Machulla HJ, Stoecklin G (1980) Myocardial imaging and metabolic studies with [17-I-123]iodoheptadecanoic acid. J Nucl Med 21:1043–1050
Freundlieb C, Hoeck A, Vyska K, Erbel R, Feinendegen LE (1982) Fatty acid uptake and turnover rate in the ischemic heart before and after bypass surgery. In: Raynaud C (ed) Proceedings of the 3rd World Congress on Nuclear Medicine and Biology, Paris, 1982, vol 2. Pergamon Press, Oxford New York, pp 1392–1395
Goodale WT, Hackel DB (1953) Myocardial carbohydrate metabolism in normal dogs, with effects of hyperglycemia and starvation. Circ Res 1:509–517
Hoeck A, Freundlieb C, Vyska K, Loesse B, Erbel R, Feinendegen LE (1983) Myocardial imaging and metabolic studies with [17-I-123]iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy. J Nucl Med 24:22–28
Kline R, Rizi H, Mangner T, Besozzi M, Thrall J, Swanson D, Copp J, Brown L, Beierwaltes W (1981) Myocardial imaging in humans with I-123-plamitic acid. J Nucl Med 22:P29
Miller HI, Yum KY, Durham BC (1971). Myocardial free fatty acid uptake in unanesthetized dogs at rest and during exercise. J Physiol 220:589–594
Most AS, Brachfeld N, Gorlin R, Wahren J (1969) Free fatty acid metabolism of the human heart at rest. J Clin Invest 48:1177–1188
Neely JR, Rovetto MJ, Oram JF (1972) Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 15:289–329
Opie LH (1968) Metabolism of the heart in health and disase. Am Heart J 76:685–698
Poe ND, Robinson GD Jr., MacDonald NS (1975) Myocardial extraction of labeled long-chain fatty acid analogs. Proc Soc Exp Biol Med 148:215–218
Poe ND, Robinson GD Jr., Zielinski FW, Cabeen WR Jr., Smith JW, Gomes AS (1977) Myocardial imaging with I-123-hexadecenoic acid. Radiology 124:419–424
Rothlin ME, Bing RJ (1961) Extraction and release of individual free fatty acids by the heart and fat depots. J Clin Invest 40:1380–1386
Van der Wall EE, Den Hollander W, Heidendal GAK, Westera G, Majid PA, Roos JP (1981a) Dynamic myocardial scintigraphy with I-123 labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med 6:383–389
Van der Wall EE, Westera G, Den Hollander W, Visser FC (1981b) External detection of regional myocardial metabolism with radioiodinated hexadecenoic acid in the dog heart. Eur J Nucl Med 6:147–151
Van der Wall EE, Heidendal GAK, Den Hollander W, Westera G, Roos JP (1981 c) Metabolic myocardial imaging with I-123 labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 6:391–396
Van der Wall EE, Den Hollander W, Heidendal GAK, Westera G, Roos JP (1983) Myocardial scintigraphy with I-123 labelled heptadecanoic acid in patients with unstable angina pectoris. Postgrad Med J 59 (suppl 3):38–40
Vyska K, Freundlieb C, Hoeck A, Feinendegen LE, Machulla HJ, Stoecklin G (1980) Myocardial imaging and measurement of myocardial fatty acid metabolism using omega-I-123-heptadecanoic acid. Adv Clin Cardiol 1:422–436
Weiss ES, Hoffman EJ, Phelps ME, Welch MJ, Henry PD, Ter-Pogossian MM, Sobel BE (1976) External detection and visualization of myocardial ischemia with C-11-substrates in vitro and in vivo. Circ Res 39:24–32
Westera G, Van der Wall EE, Heidendal GAK, Van den Bos GC (1980) A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and T1-201-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imaging. Eur J Nucl Med 5:339–343
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Visser, F.C., van Eenige, M.J., van der Wall, E.E. et al. The elimination rate of 123I-heptadecanoic acid after intracoronary and intravenous administration. Eur J Nucl Med 11, 114–119 (1985). https://doi.org/10.1007/BF00265043
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265043